Papulonecrotic tuberculid-clinicopathologic and molecular features of 12 Indian patients

Rajalakshmi Tirumalae1, Inchara K Yeliur1, Meryl Antony1

  • 1Departments of Pathology & Dermatology, St. John's Medical College & Hospital, Bangalore, India.

Abstract

Insights

Papulonecrotic tuberculid (PNT) is a rare skin condition. Detecting Mycobacterium tuberculosis DNA via PCR in some cases suggests PNT might be a form of cutaneous tuberculosis requiring systemic screening.

Area of Science:

  • Dermatology
  • Infectious Diseases
  • Microbiology

Background:

  • Papulonecrotic tuberculid (PNT) is considered a hypersensitivity reaction to Mycobacterium tuberculosis.
  • Some studies suggest the presence of M. tuberculosis organisms in PNT lesions, detectable by polymerase chain reaction (PCR).

Purpose of the Study:

  • To describe the clinical and histopathologic features of 12 patients diagnosed with PNT.
  • To investigate the presence of M. tuberculosis DNA in PNT lesions using PCR.
  • To evaluate treatment outcomes and disease classification.

Main Methods:

  • Retrospective review of 12 PNT patients over 6 years.
  • Analysis of histopathologic features, clinical data, and follow-up.
  • Polymerase chain reaction (PCR) for M. tuberculosis DNA in all cases.

Main Results:

  • The study included 12 patients (7 males, 5 females; ages 3-58).
  • Upper limbs were most commonly affected (8 cases); lesions were papulonodular, with 5 showing ulceration/scarring.
  • Mycobacterial DNA was detected by PCR in 3 cases; 7 patients showed improvement with treatment.

Conclusions:

  • PNT is a rare condition, and positive PCR results raise questions about its classification as a
  • The findings suggest PNT could be a manifestation of true cutaneous tuberculosis, necessitating screening for systemic disease.
  • PNT management may benefit from considering it as true cutaneous tuberculosis.

Related Concept Videos

Pulmonary Tuberculosis III01:31

Pulmonary Tuberculosis III

Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
1.7K
Pulmonary Tuberculosis IV01:26

Pulmonary Tuberculosis IV

Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
810
Pulmonary Tuberculosis II01:28

Pulmonary Tuberculosis II

Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
2.4K
Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
1.7K
Pulmonary Tuberculosis V01:28

Pulmonary Tuberculosis V

Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
984
NF-κB-dependent Signaling Pathway02:26

NF-κB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The...
7.5K